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Abstract 
Aim: A multidisciplinary approach, including dietetics, is considered the optimal model of care for dialysis 
preparation. Dietetic consultation (DC) focuses on symptom management and dietary changes to delay 
time to dialysis. Evidence of the effectiveness of DC on time to dialysis is limited. This study aimed to 
investigate the impact of DC on time to dialysis for patients attending a pre-dialysis clinic. Methods: A 
retrospective cohort study was designed to include all patients attending outpatient pre-dialysis clinics at 
a large metropolitan renal service between January 2014 and March 2018. Time to dialysis (days) was 
compared between patients that received DC and those who did not. Cox proportional hazards analysis 
allowing for adjustment of differences and confounders was undertaken. Results: A cohort of 246 
patients was identified. Median estimated glomerular filtration rate was 16mL/min per 1.73 m2 
(interquartile range = 13-20) at initial pre-dialysis clinic visit and 63% commenced dialysis during the 
study period. Only 41% of patients received dietetic consultation. Significantly fewer patients needed to 
commence dialysis in the DC group compared to the no-DC group (hazards ratio 0.63; 95% confidence 
interval (CI) 0.45-0.89; P = 0.008 Cox proportion hazard). The DC group commenced dialysis significantly 
later than the no-DC group; 933 days (95% CI 832-1034) versus 710 days (95% CI 630-790) respectively, 
after the initial pre-dialysis clinic visit; log-rank 0.005. Conclusion: DC provided to patients attending a pre-
dialysis clinic was associated with a delayed time to dialysis. Standardised referral pathways to improve 
patient access to renal dietetic services are recommended to optimise care. 
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Background: A multidisciplinary approach, including dietetics, is considered the 3	
optimal model of care for dialysis preparation. Dietetic consultation focuses on 4	
symptom management and dietary changes to delay time to dialysis. Evidence of the 5	
effectiveness of dietetic consultation on time to dialysis is limited. This study aimed 6	
to investigate the impact of dietetic consultation on time to dialysis for patients 7	
attending a pre-dialysis clinic. 8	
Methods: A retrospective cohort study was designed to include all patients attending 9	
outpatient pre-dialysis clinics at a large metropolitan renal service between January 10	
2014-March 2018. Time to dialysis (days) was compared between patients that 11	
received dietetic consultation and those who did not. Cox proportional hazards 12	
analysis allowing for adjustment of differences and confounders was undertaken. 13	
Results: A cohort of 246 patients was identified. Median eGFR was 16ml/min/1.73m2 14	
(IQR = 13-20) at initial pre-dialysis clinic visit and 63% commenced dialysis during 15	
the study period. Only 41% of patients received dietetic consultation. Significantly 16	
fewer patients needed to commence dialysis in the dietetic consultation group 17	
compared to the no- dietetic consultation group (HR 0.63; 95% CI 0.45-0.89;P=0.008 18	
Cox proportion hazard).  The dietetic consultation group commenced dialysis 19	
significantly later than the no-dietetic consultation group; 933 days (95% CI 832-20	
1034) versus 710 days (95% CI 630-790) respectively, after the initial pre-dialysis 21	
clinic visit; log rank 0.005. 22	
Conclusions: Dietetic consultation provided to patients attending a pre-dialysis clinic 23	
was associated with a delayed time to dialysis. Standardised referral pathways to 24	
improve patient access to renal dietetic services are recommended to optimise care. 25	
	 2	
Keywords: Chronic kidney disease, pre-dialysis care, dietetic consultation, nutrition 26	




Nutrition therapy is a key component of chronic kidney disease (CKD) treatment(1) 31	
and a multidisciplinary team (MDT) approach, including dietetics, has been reported 32	
as the most effective model of care for optimal dialysis preparation(2). Nutrition 33	
therapy for pre-dialysis is used to address comorbidities associated with progression 34	
(such as hypertension, hyperglycemia and proteinuria), manage nutrition-related 35	
uraemic symptoms and reduce the risk of protein-energy malnutrition(2-4). Adequate 36	
caloric intake and reductions in dietary sodium, protein, fluid and electrolytes such as 37	
potassium and phosphate (when indicated) are required to manage advanced CKD and 38	
progression factors(1, 5-8). 39	
 40	
While dietetic consultation (DC) for patients with advanced CKD (Stages 4-5) is 41	
recommended(9), standardised referral pathways to dietitians are not commonplace in 42	
renal services and DC is often under-appreciated in CKD management(2, 10). Further, 43	
healthcare costs of managing CKD and facilitating dialysis have placed an immense 44	
burden on health care systems worldwide(3, 11). Thus, interventions focused on 45	
delaying disease progression have been recommended(12). Delaying dialysis has been 46	
reported by patients as a significant motivator for dietary change(13). This idea has 47	
been mostly explored in patients on dialysis, which may have previously 48	
underestimated the role of DC in delaying CKD progression(14). Whilst pre-dialysis 49	
presents an opportune intervention period for CKD, evidence on the impact of DC on 50	
	 3	
delaying dialysis is limited. It is hypothesised that DC may delay time to dialysis 51	
(TTD) and a retrospective study was designed to investigate TTD for patients who 52	
received DC compared to those who did not.   53	
 54	
MATERIALS AND METHODS  55	
 56	
Study Design and Population  57	
This research was a retrospective, multi-center cohort study of patients attending pre-58	
dialysis clinic services within the South Western Sydney Local Health District 59	
(SWSLHD) in Sydney, New South Wales (NSW), Australia. This district provides 60	
dialysis services to 18% of the NSW population on dialysis(15).  61	
 62	
Patients with an estimated glomerular filtration rate (eGFR) <20 ml/min/1.73m2, are 63	
routinely referred to pre-dialysis clinics by their nephrologist. The pre-dialysis clinics 64	
are facilitated by a single pre-dialysis nurse who works across three major hospitals 65	
within SWSLHD. Following an initial pre-dialysis visit, all patients were offered a 66	
referral for DC. The DC was individualised and dependent on each patient’s stage of 67	
CKD, electrolyte abnormalities present (potassium and phosphate) and nutrition status. 68	
Recommendations provided in the pre-dialysis dietetic clinic generally covered a low-69	
moderate protein, low sodium, lower potassium and phosphate diet (as indicated).  70	
 71	
All patients who attended the pre-dialysis clinics from January 1, 2014 to June 30, 72	
2016 were included in the study. Patient outcomes were followed until March 31, 73	
2018. This timeframe was chosen to allow for sufficient follow-up of at least 12 74	
months to observe measurable changes in kidney function. Exclusion criteria were 75	
	 4	
less than 18 years of age, had dialysis education for an acute kidney injury, opted for 76	
a non-dialysis therapeutic modality (renal supportive care), commenced dialysis or 77	
died within three months of initial pre-dialysis clinic visit, received a transplant prior 78	
to dialysis commencement, living with life-limiting morbidities (e.g. terminal cancer 79	
and/or concurrent radiotherapy/chemotherapy) and those with missing data such as 80	
medical history. Ethics approval for this study was obtained from SWSLHD Human 81	
Research Ethics Committee (HE18/196). Requirement for informed consent was 82	
waived. 83	
 84	
Data Collection  85	
 86	
Patients were identified from the database maintained by the pre-dialysis nurse to 87	
determine eligibility for the study. Baseline and follow-up data were obtained from 88	
electronic medical records and nephrologist clinic letters. Patients were separated into 89	
two groups, those who received DC and those who did not. For both study groups, 90	
baseline was considered as the date of their initial visit to the clinic with the pre-91	
dialysis nurse.  Data collected at baseline included age, gender, primary language 92	
spoken, living arrangements, cause of CKD, eGFR (ml/min/1.73m2, CKD-EPI 93	
formula, hospital/private pathology center, within a three month period prior to the 94	
initial pre-dialysis clinic visit with the coordinator), co-morbidities and blood pressure 95	
control. Co-morbidities included diabetes, hypertension, ischemic heart disease (IHD), 96	
cerebrovascular disease, congestive heart failure (CHF), chronic obstructive 97	
pulmonary disease (COPD), cancer (not undergoing active treatment) and obesity. 98	
Blood pressure control was collected within six months prior to baseline and 3-6 99	
	 5	
months post the initial pre-dialysis visit. Well-controlled blood pressure was defined 100	
as <140/90mmHg(16). 101	
 102	
For patients who had not commenced dialysis, follow-up consisted of the number of 103	
days they remained in the pre-dialysis service and most recent eGFR up until March 104	
31, 2018 (within 3-4 months of the follow-up date). For patients that had commenced 105	
dialysis or passed away (prior to requiring dialysis) within this time, the date of their 106	
first dialysis session or date of death was recorded respectively. Dialysis modality 107	
(haemodialysis or peritoneal dialysis), access type (tunneled vascular catheter, 108	
arterial-venous fistula or peritoneal dialysis catheter), serum potassium (mmol/L), 109	
phosphate (mmol/dL), albumin (µmol/L) and eGFR (ml/min/1.73m2, CKD-EPI 110	
formula) at the first dialysis session were obtained. Additional data collected for both 111	
groups included DC (yes/no), number of DC attended, number of hospital admissions 112	
and new major adverse cardiac events (MACE), from baseline to follow-up. MACE 113	
was defined as cardiac death, nonfatal myocardial infarction, or target lesion 114	
revascularization(17). Myocardial infarction was defined by a rise in high sensitivity 115	
troponin T (> 20% increase from previous baseline) in addition to ischaemic 116	
symptoms, new electrocardiogram changes, or identification of an intracoronary 117	
thrombus by angiography(18). 118	
 119	
Data collection was undertaken by three investigators (SN, LG & PL) and a protocol 120	
was developed to ensure agreement on consistent and accurate methods for data 121	
collection.  Where there was disagreement or ambiguity, discussions between the 122	
three investigators and the project supervisors (MM & AM) were undertaken until a 123	
consensus was reached. No pre-existing data on TTD based on DC were available to 124	
	 6	
complete a power analysis. Thus, the study’s sample size was based on the number of 125	
patients available during the study period.  126	
 127	
Patient characteristics were compared to those from the Australian New Zealand 128	
Dialysis and Transplant (ANZDATA) registry(15) to assess if the study cohort was a 129	
representation of the general Australian population on dialysis. Characteristics 130	
compared included gender, age, primary cause of CKD, diagnosis of heart disease, 131	
cerebrovascular disease and chronic lung disease. 132	
 133	
Statistical Analysis  134	
 135	
Continuous variables were assessed for normality using the Shapiro-Wilk test. 136	
Normally distributed data are presented as the mean with standard deviation (SD) and 137	
assessed between groups using an independent t-test. Non-normally distributed data 138	
are presented as the median with interquartile range and assessed between groups 139	
using the Mann-Whitney U test. Categorical variables were presented as frequency 140	
(%) and assessed using the Fisher’s Exact or Chi-Square test.  141	
 142	
Unadjusted Kaplan-Meier time-to-event curves with log-rank test were used to 143	
compare the primary outcome of TTD between the two groups.  Participants who had 144	
not started dialysis were censored at the set date of follow-up (March 31, 3018). 145	
Univariate and multivariate Cox proportional hazard models were used to determine 146	
associations between TTD and independent variables. Hazard ratios with 95% 147	
confidence intervals were calculated. A step-wise backward regression analysis was 148	
used to identify the variables that were independent predictors of TTD from those 149	
	 7	
found to be significant in the univariate analysis. Variables significantly different 150	
between the two groups and known confounders of CKD progression were included 151	
in the model. Probabilities for entry or removal of variables from the model were 0.05 152	
and 0.1, respectively.  153	
 154	
Missing data was specified and all data available was included in the analysis. There 155	
was no imputation of missing data. The data was analysed using Statistical Package 156	
for the Social Sciences (SPSS) (Version 25; IBM Corp, Armonk, NY). A P value < 157	
0.05 was considered statistically significant. Reporting of this study followed the 158	





Baseline Characteristics  164	
 165	
A total of 363 patients were seen in the pre-dialysis service between January 2014-166	
June 2016. Overall, 246 patients were eligible for the study and 117 patients were 167	
excluded (Figure 1). Data on age, gender, primary language spoken, living 168	
arrangements, cause of CKD, eGFR, co-morbidities and starting date of dialysis (if 169	
applicable) were collected for 100% of patients.  Baseline characteristics of all 170	
patients are summarised in Table 1. Despite all patients being offered a dietitian 171	
appointment, only 41% (n = 102) accepted DC.  Reasons for non-attendance were not 172	
recorded. Clinic blood pressure assessments were available for 197 out of 246 patients 173	
	 8	
(80%). Blood pressure was considered well controlled (target of <140/90mmg Hg) for 174	
65% of patients. No pattern in missing data was identified between the two groups. 175	
 176	
Median eGFR at baseline for all patients was 16 ml/min/1.73m2 (Interquartile Range 177	
(IQR) = 13-20) and there was a significant difference between the DC and no-DC 178	
groups (DC group median 17 (IQR = 14-22) versus no-DC group median 15 (12-19); 179	
P=0.005). Patients received DC at a median time of 39 days (IQR 0-99 days) post 180	
initial education with the pre-dialysis nurse.  Some patients (30%) received DC on the 181	
same day they attended the initial pre-dialysis education. Overall, 100% of patients in 182	
the DC group attended one consult, 26% attended two consults and 17% attended 183	
more than three consults.  184	
 185	
A comparison between the study cohort and NSW ANZDATA dialysis population on 186	
(supplementary data) was undertaken to assess the difference between the study 187	
cohort and general NSW population on dialysis. When compared to the NSW 188	
population undertaking dialysis, this study’s cohort had a significantly higher 189	
proportion of patients with diabetic nephropathy as the cause of CKD (53% versus 190	
33%; P<0.001), a higher proportion of patients with diabetes (63% versus 48%; 191	
P<0.001) and a lower proportion of patients with heart disease (26% versus 37%; 192	
P<0.001), cerebrovascular disease (8% versus 14%; P=0.007) and chronic lung 193	





Dialysis was commenced by 155 patients (63%). The median TTD was 451 days 198	
(IQR = 278-646) from the initial pre-dialysis clinic visit. Patients in the DC group had 199	
a significantly longer TTD compared to the no-DC group (median TTD 523 days 200	
versus 375 days, P=0.003)(Table 2) and showed a trend towards significance of a 201	
lower mortality rate at the end of the follow-up period (8% versus 17%; P=0.05).  202	
 203	
Kaplan-Meier unadjusted survival analysis of time in the pre-dialysis service prior to 204	
commencing dialysis based on DC (Figure 2) indicated a significant difference 205	
between the two groups of 223 days (approximately 7.5 months). DC was associated 206	
with a slower progression to dialysis from the initial pre-dialysis clinic visit (933 days 207	
(95% CI 832-1034) versus 710 days (95% CI 630-790) respectively; log-rank 208	
P=0.005).  209	
Univariate analysis using a Cox proportional hazards model to assess the association 210	
with TTD was shown in Table 3. DC (P=0.006), eGFR (P<0.001), age (P=0.003) and 211	
diabetes (P=0.005) were significantly associated with TTD (Table 3). The other six 212	
variables analyzed, IHD, CHD, COPD, well-controlled blood pressure post pre-213	
dialysis nurse education, not-well controlled blood pressure post pre-dialysis nurse 214	
education, language spoken, smoking and gender were not found to be significant. 215	
 216	
Multivariate analysis using a Cox proportional hazards regression model of the four 217	
variables found to be significant in the univariate analysis was undertaken (Table 3). 218	
DC (HR 0.63, 95% CI 0.45-0.89, P=0.008), even when adjusted for other significant 219	
variables and face-confounders was associated with a reduction in the risk of 220	
commencing dialysis. eGFR at initial pre-dialysis nurse education (HR 0.89, 95% CI 221	
0.86-0.92, P<0.001) and age at initial pre-dialysis nurse education (HR 0.97, 95% CI 222	
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0.96-0.98, P<0.001) were associated with a reduced risk of commencing dialysis by 223	
the end of the follow-up period. Diabetes (HR 1.81, 95% CI 1.28-2.56, P=0.001) was 224	
associated with a higher risk of needing dialysis.  225	
 226	
DISCUSSION 227	
This retrospective cohort study of patients attending a pre-dialysis service found DC 228	
was associated with a significant delay in TTD of 7.5 months and a 37% lower chance 229	
of commencing dialysis within the four-year study period. This study adds to the 230	
limited literature on pre-dialysis DC outcomes and provides valuable input on the 231	
outcome of TTD for a cohort of individuals who received DC and were followed up 232	
for >12 months.  233	
 234	
A retrospective analysis of TTD over a 10-year follow-up period of 265 patients, 235	
found patients with CKD Stages 3-4 that did not receive DC were 3.47 and 3.45 times 236	
more likely to commence dialysis, respectively, compared to patients that received 237	
DC(3). This analysis was adjusted for laboratory parameters and diabetes. However, 238	
no other confounding factors were analysed. No significant differences were found on 239	
TTD based on DC for patients with CKD Stage 5 or those that commenced dialysis 240	
<365 days from CKD diagnosis or initial DC. In contrast, the current analysis found a 241	
significant difference in TTD for patients with CKD Stage 5 that received DC, 242	
indicating a positive association between DC and outcomes even in advanced CKD. 243	
This positive difference was observed in the absence of direct measures of patient 244	
compliance with DC or the effectiveness of the dietitians’ nutrition counseling skills.  245	
 246	
	 11	
Low protein diets implemented with dietetic input in pre-dialysis patients were found 247	
to reduce uraemic symptoms, reduce GFR deterioration significantly (4.5mL/min 248	
versus 10mL/min over six months) and delay TTD by six months(20).  These results 249	
are consistent with our study, which found a difference of approximately 7.5 months 250	
in delaying TTD. Uraemic symptoms are known to be primary predictors for dialysis 251	
initiation and all cause mortality(21). Thus, DC aimed at addressing uraemic symptoms 252	
such as lower protein diets may have a positive impact on delaying TTD.  In a 253	
randomised controlled trial, a low protein vegan diet was found to postpone dialysis 254	
initiation by 10-11 months in elderly patients with an eGFR of 5-6 ml/min/1.73m2(22).  255	
 256	
Further, the benefits of pre-dialysis DC have been found to extend into the first year 257	
of dialysis(10). A retrospective study that included 156,440 patients on haemodialysis, 258	
found significant improvements in mortality (HR 0.85) in patients who received DC 259	
for >12 months prior to dialysis(10). However, only 12% of patients had received pre-260	
dialysis DC as per 2005-2007 US Centres for Medicare & Medicaid Services Medical 261	
Evidence Reports. These results are not surprising given Medicare coverage for DC in 262	
non-dialysis dependent patients commenced in 2002 and under-utilization of these 263	
services by physicians has been documented as a barrier to patients accessing pre-264	
dialysis DC(23).  Instead, DC often occurs for the first time once patients have 265	
commenced dialysis, as US dialysis centres are mandated to provide dietetic 266	
services(10, 23).  Australian data on the number of patients that receive pre-dialysis DC 267	
has not been previously published for comparison.  Replication of a similar 268	
retrospective cohort study on the impact of DC on TTD with a larger sample size in 269	
differing cultural contexts would be useful to confirm the findings presented. This 270	
may have implications to strengthen the case for mandating DC into pre-dialysis care. 271	
	 12	
 272	
With average annual heath care costs per patient for dialysis equivalent to 273	
AUS$80,000; delaying dialysis should be a target of health service delivery(3, 12). The 274	
results of this study indicate that DC could delay TTD by 223 days. According to the 275	
most recent ANZDATA registry report, 2823 patients commenced dialysis in 2016 in 276	
Australia(15). If dialysis commencement could be postponed in patients through DC, 277	
this could equate to significant economic savings for health care systems. However, 278	
DC is often an overlooked and under-appreciated aspect of CKD management in 279	
health service delivery, with reporting of inadequate dietetic staffing to patient 280	
ratios(24, 25).  281	
 282	
Health economic modeling is often focused on pharmaceutical or surgical treatments 283	
that may improve quality and quantity of life in CKD to determine health care 284	
spending(11, 26, 27). A one-year delay in dialysis is predicted to gain 0.6 quality-adjusted 285	
life years (QALYs) and 0.3 years in productivity per person(26). Few studies have 286	
assessed the cost-effectiveness of DC. The economic benefit of a low protein diet in 287	
patients to delay TTD, reported an estimated increase in QALYs of 0.10, 0.39 and 288	
0.93 after 2, 5 and 10 years, respectively(27). In a US modeling study, renal MDT care, 289	
including dietetics, was estimated to add 0.23 QALYs over usual care, reducing the 290	
need for dialysis and improving life expectancy for patients with CKD Stages 3-4(28). 291	
This model included 2-4 DC per year for patients with CKD Stages 3-5. Whilst these 292	
cost-effectiveness models predict promising outcomes from DC, more health 293	
economic studies based on health systems involved are necessary. 294	
 295	
	 13	
Study limitations included the dependence on clinical documentation to undertake 296	
data collection. Whilst most data planned for collection was obtained, incomplete 297	
medical records were encountered, particularly with blood pressure control. However, 298	
this did not have an association with TTD. Proteinuria, a CKD progression factor 299	
could not be obtained through clinical documentation. Patients in the no-DC group 300	
had a significantly higher prevalence of IHD and COPD and a lower eGFR than those 301	
in the DC group at baseline that may have introduced bias. However, IHD and COPD 302	
did not show an association with TTD in the analysis. Selection bias is possible, as 303	
patients with higher motivation may have accepted the dietetic referral compared to 304	
those that declined. Reasons for non-attendance to the pre-dialysis dietetic clinic were 305	
not available. The type of DC provided was not collected, thus associations between 306	
the different components of dietetic interventions (that is, protein, potassium, 307	
phosphate or sodium restriction) could not be made. Lastly, given the retrospective 308	
observational nature of the study, the risk of residual confounding factors cannot be 309	
excluded and a cause and effect relationship cannot be confirmed.  310	
 311	
Despite these limitations, the findings are important for the wider CKD population. 312	
The study cohort had a significantly higher co-morbid burden of diabetes and diabetes 313	
as the cause of CKD compared to the general CKD population in NSW. In this study,  314	
diabetes was found to be negatively associated with TTD (HR 1.81), with these 315	
patients commencing dialysis quicker than those without diabetes.  In larger 316	
observational studies, diabetes has also been found as a predictor of progression to 317	
CKD Stage 5(29). Thus, in the wider NSW CKD population that has lower rates of 318	
diabetes, DC may potentially delay TTD further compared to the results obtained in 319	
this study. Based on the study results, a post-analysis sample size calculation found 320	
	 14	
the study to be adequately powered. Given the effect of DC, to be able to reject the 321	
null hypothesis, 128 control subjects (no-DC) and 91 experimental subjects (DC) 322	
were required to reach 80% power. Although, post-hoc calculations are not as reliable 323	
as pre-specified power calculations, this may provide guidance for the design of 324	




DC in pre-dialysis clinics may be considered a useful, potentially cost-saving therapy 329	
to delay TTD and reduce eGFR decline. As this study did not address dietary 330	
compliance rather just the occurrence of DC, further prospective research is needed to 331	
investigate the effectiveness of DC from earlier stages of CKD with eGFR and TTD 332	
as primary outcomes. Increased dietetic staffing in renal units and earlier access to 333	
dietetic services are recommended to maximise the benefits of DC for CKD 334	
management and delay TTD.  335	
 336	
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 (n = 246) 
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• Supportive care (n= 27) 
• Missing data entries (n= 40) 
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Figure 2: Unadjusted Kaplan-Meier survival analysis for time to dialysis based on 




Table 1: Baseline characteristics of study participants 
 
Characteristic (Baseline) 
Total   
(n = 246)        
Did not receive 
dietetic 
consultation 
 (n = 144) 
Received 
dietetic 
consultation           
(n = 102) P Value  
Age (years) 64 (51-72) 64  (53-72) 63 (50-71) 0.4 
Gender         
Male  164 (67) 100 (69) 64 (63) 0.3 
Language Spoken        0.006* 
English  164 (67) 86 (60) 78 (77)   
Other 82 (33) 58 (40) 24 (23)   
Living arrangements        0.9 
Family 213 (87) 125 (87) 88 (86)   
Friends 3 (1)  2 (1) 1 (1)   
Alone 25 (10) 13 (9) 12 (12)   
Other (e.g nursing home, hostel) 5 (2) 4 (3) 1 (1)   
Cause of CKD       0.3 
Diabetes 131 (53) 82 (57) 49 (48)   
Hypertension  26 (11) 17 (12) 9 (9)   
Immune-related 39 (16) 23 (16) 16 (16)   
Structural 10 (4) 5 (3) 5 (5)   
Other 12 (5) 4 (3) 8 (8)   
Unknown  28 (11) 13 (9) 15 (15)   
eGFR (ml/min/1.73m2)    0.003* 
<10 25 (10) 10 (7) 15 (15)  
11-20 166 (67) 93 (65) 73 (71)  
21-30 50 (20) 39 (27) 11 (11)  
31-40 5 (2) 2 (1) 3 (3)  
Average 16 (13-20)  15 (12-19) 17 (14-22)  0.005* 
CKD Stage    0.002*  
3-4 152 (62) 77 (53) 75 (74)  
5 94 (38) 67 (47) 27 (26)   
Co-morbidities         
Diabetes 154 (63) 96 (67) 58 (57) 0.1 
Hypertension 225 (92) 130 (90) 95 (93) 0.5 
Hyperlipidemia 143 (58) 84 (58) 59 (58) 1.0 
Ischemic heart disease 65 (26) 47 (33) 18 (18) 0.01* 
Congestive heart failure 29 (12) 21 (15) 8 (8) 0.1 
COPD 19 (8) 16 (11) 3 (3) 0.03* 
Cerebrovascular disease 20 (8) 13 (9) 7 (7) 0.7 
Cancer 25 (10) 13 (9) 12 (12) 0.5 
Obesity  71 (29) 35 (24) 36 (35) 0.07 
Blood pressure well-controlled  
    (n = 197) 128 (65) 73 (57) 55 (43) 0.9 
Currently smoking 17 (7) 10 (7) 7 (7) 1.0 
 
	 20	
Data are expressed as n (%) or mean (SD) for categorical and continuous parametric 
data variables, respectively and median (interquartile range) for the non-parametric 
data. Statistical significance was assessed between the group that did not receive 
dietetic consultation and the group that received dietetic consultation. CKD indicates 
chronic kidney disease; eGFR indicates estimated glomerular filtration rate.  
Fisher’s exact test used for categorical variables. Mann-Whitney U test or 




Table 2: Follow-up characteristics and outcomes of study participants 
 
Data are expressed as n (%) or mean (SD). Statistical significance was assessed between 
the group that did not receive dietetic consultation and the group that received dietetic 
consultation. AV indicates arterial-venous; eGFR, estimated glomerular filtration rate; 
MACE, major adverse cardiac event. Fisher’s exact test used for categorical variables. 
Mann-Whitney U test or Independent t-test used for continuous variables. *Indicates P 
value <0.05. 









(n = 102) P Value 
 
        
Patients on dialysis  155 (63) 97 (67) 58 (57) 0.1 
Time to dialysis (days) 451 (278-646) 375 (253-562) 523 (420-696) 0.003* 
Dialysis Modality        0.02* 
Haemodialysis 62 (40) 32 (33) 30 (52)   
Peritoneal dialysis  93 (60) 65 (67) 28 (48)   
Access type at dialysis commencement        0.01* 
AV fistula/graft 30 (19) 12 (12) 18 (31)   
Vascular catheter 32 (21) 20 (21) 12 (21)   
PD catheter 93 (60) 65 (67) 28 (48)   
Blood test results at first dialysis session         
eGFR (mL/min/1.73m2) 8 (6-10) 8.0 (6-10) 8.0 (7-11) 0.4 
Potassium (mmol/L) 4.8 (0.7) 4.9 (0.7) 4.7 (0.7) 0.06 
Phosphate (mmol/L) 1.9 (1.6-2.3) 2.0 (1.6-2.4) 1.9 (1.6-2.2) 0.6 
Albumin (µmol/L) 37 (32-41) 37 (31-41) 38 (34-42) 0.1 
Drop in eGFR from baseline-follow up (%) 20.7 (5.8-42.6) 24.5 (0-50.5) 18 (8.0-33) 
 
0.1 
Patients admitted to hospital pre-dialysis 143 (58) 91 (63) 52 (51) 
 
0.06 
Number of hospital admissions/person 1 (0-2) 1 (0-2) 1 (0-2) 0.2 
 




Total deaths 32 (13) 24 (17) 8 (8) 
 
0.05 
    Pre-dialysis (% of deaths) 13  10  3   
    Post-dialysis (% of deaths) 19  14  5   
 




Table 3: Univariate and multivariate analysis with cox proportional hazard model to  
examine the effect of variables on time to dialysis (in days). 
 
  Univariate Analysis Multivariate Analysis 
Variable HR 95% CI P Value HR 95% CI P Value 
Age on admission 0.98 0.97-0.99 0.003* 0.97 0.96-0.98 <0.001* 
eGFR on admission  0.9 0.87-0.93 <0.001* 0.89 0.86-0.92 <0.001* 
Male gender 0.99 0.71-1.38 0.9       
Ischemic heart disease 1.12 0.78-1.6 0.5       
COPD 0.67 0.34-1.31 0.2       
Diabetes 1.61 1.15-2.26 0.005* 1.81 1.28-2.56 0.001* 
Congestive Heart Failure 1.06 0.64-1.76 0.8       
BP – well controlled  1.1 0.88-1.41 0.4    
BP – not well controlled 1.06 0.83-1.35 0.6    
English speaking 0.95 0.68-1.33 0.8       
Smoking 1.44 0.8-2.61 0.2       
Dietetic consultation (yes/no) 0.63 0.45-0.87 0.006* 0.63 0.45-0.89 0.008* 
 
COPD indicates chronic obstructive pulmonary disease; eGFR, estimated glomerular 
filtration rate; BP, blood pressure. *Indicates P value <0.05. 
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Table 1: A comparison between the study cohort and the general NSW population on 




(n = 3987) 
SWSLHD 
(n = 246) P Value 
Age       
55-64 years 850 (21) 55 (22) 0.4 
Gender       
Male 2463 (62) 164 (67) 0.1 
Cause of Chronic Kidney 
Disease       
Diabetes 1325 (33) 131 (53) <0.001* 
Co-morbidities       
Diabetes 1920 (48) 154 (63) <0.001* 
Heart Disease 1481 (37) 65 (26) 0.001* 
Cerebrovascular Disease 570 (14) 20 (8) 0.007* 
Chronic Lung Disease 643 (16) 19 (8) <0.001* 
 
Data are expressed as n (%) NSW indicates New South Wales; SWSLHD, South 
Western Sydney Local Health District. Chi-square test used to analysis variables.  
	
